Navigation Links
Clinical Data for BackBeat Medical's Programmable Hypertension Control Therapy to Be Presented at ICI Meeting 2016
Date:11/29/2016

NEW HOPE, Pa., Nov. 29, 2016 /PRNewswire/ -- BackBeat Medical Inc., a medical technology company developing novel cardiac stimulation-based therapies for hypertension and heart failure, today announced that clinical data for the company's patented Programmable Hypertension Control (PHC) therapy will be presented at the Innovations in Cardiovascular Interventions (ICI) Meeting 2016, Dec. 4-6, in Tel Aviv, Israel.

The presentation will feature results from the first-in-man study of BackBeat's PHC therapy including two years of follow-up data from patients who received BackBeat's Moderato™ pacemaker incorporating the company's proprietary pacing algorithms. Dr. Yuval Mika, CEO and co-founder, will deliver the presentation "Programmable Hypertension Control (PHC) - A Pacemaker-Mediated Novel Approach for the Treatment of Hypertension" during the session "Technology Parade I - Devices" at 9:50 a.m. IST on Monday, Dec. 5 in Room 4 at the David Intercontinental Convention Center.

About BackBeat Medical

BackBeat Medical Inc. is a medical technology company founded in 2010 to develop novel cardiac stimulation-based therapies for hypertension and heart failure. BackBeat has developed a patented cardiac pacing-based treatment for hypertension (HTN) called programmable hypertension control (PHC) therapy. PHC is comprised of proprietary pacing algorithms that can be readily incorporated into standard pacemakers using standard leads and standard lead placement and thus has broad applicability. PHC offers a new potent device-based HTN therapeutic alternative potentially opening up a large market to treat HTN patients, particularly HTN patients who already have or require a pacemaker. Clinical results generated to date using BackBeat's own Moderato™ pacemaker incorporating PHC algorithms demonstrate that this therapy has a substantial and sustained therapeutic effect on blood pressure as determined by both in-office cuff measurements (average reduction of 24 mmHg from baseline) and 24-hour ambulatory measurements (average reduction of 14 mmHg from baseline) with clinical follow up extending up to two years.

Media Contacts:                                                                              

David Schull or Todd Davenport, Ph.D.
Russo Partners, LLC
(212) 845-4271
(212) 845-4235
david.schull@russopartnersllc.com 
todd.davenport@russopartnersllc.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/clinical-data-for-backbeat-medicals-programmable-hypertension-control-therapy-to-be-presented-at-ici-meeting-2016-300370035.html


'/>"/>
SOURCE BackBeat Medical Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Edgemont Capital Completes Sale Of Vince & Associates Clinical Research
2. Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
3. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
4. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
5. A*STAR and Cytos Bring Singapores First Influenza Vaccine to Clinical Testing
6. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
7. Hyland Software Forms Multi-Disciplinary Clinical Leadership Team to Augment Healthcare Solutions
8. Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer
9. Rigels R348 to Initiate Phase 2 Clinical Trial in Dry Eye
10. Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer
11. Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... Sept. 25, 2017   Montrium , an ... solutions, today—from the IQPC Trial Master Files & ... NL)—announced that EastHORN Clinical Services has selected ... and TMF management. EastHORN, a leading European contract ... to increase transparency to enable greater collaboration with ...
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills ... specialty vendors and unique items from across the nation, this holiday-themed event will raise ... offered by the VNA. The boutique will be open Saturday, November 4 (10:00 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... ... ... Planet Fitness, one of the largest and fastest growing franchisors and operators ... location in Covington, LA at 401 N. U.S. Highway 190, in January of 2018. ... in the Holiday Square shopping center. Its location allows it to serve both Covington ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):